NCT00784992

Brief Summary

Aim of study is to investigate whether the use of silicone tubes in endonasal DCR surgery increases the success rate and / or complication rate compared to surgery without tubes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for phase_4

Timeline
Completed

Started Nov 2008

Longer than P75 for phase_4

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2008

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

November 4, 2008

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 5, 2008

Completed
7.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 2, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 2, 2016

Completed
Last Updated

March 3, 2017

Status Verified

March 1, 2017

Enrollment Period

7.6 years

First QC Date

November 4, 2008

Last Update Submit

March 1, 2017

Conditions

Keywords

NLDODCRsilicone tubesstent

Outcome Measures

Primary Outcomes (1)

  • The primary end point will be functional success, determined by patient-reported symptoms. This will be assessed a minimum of six months post-operatively. In patients with tubes these will be removed at 3 months post-operatively.

    6 months

Secondary Outcomes (1)

  • The secondary end point will be anatomical success, as measured by patency of nasolacrimal irrigation at 6 months post-operatively. In patients with tubes these will be removed at 3 months post-operatively.

    6 months

Study Arms (2)

1

NO INTERVENTION

Endonasal DCR with silicone tubes (this is the control group since it is the standard procedure / gold standard, although the evidence base for the use of tubes is lacking, hence the need for this trial)

2

ACTIVE COMPARATOR

Endonasal DCR without silicone tubes (this is the 'intervention' arm)

Procedure: Endonasal dacryocystorhinostomy

Interventions

The standard dacryocystorhinostomy operation performed in this centre uses silicone tubes to stent open the newly created ostium between the lacrimal sac and the nasal cavity. However many surgeons in other departments / countries around the world perform the surgery without tubes. No large well-conducted RCT has been published comparing success rates / complication rates for the two techniques. For this study the control group is the arm which receives tubes (our standard procedure) and the 'interventional' group is the arm not receiving tubes. Details of the operative technique for endonasal DCR with tubes can be found in the following reference: Dolman PJ. Comparison of external dacryocystorhinostomy with nonlaser endonasal dacryocystorhinostomy. Ophthalmology. 2003 Jan;110(1):78-84. The group that will not receive tubes will undergo the same procedure except that the insertion of tubes will be omitted.

2

Eligibility Criteria

Age16 Years+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients (\> 16 years) undergoing primary DCR for NLDO who have given fully informed consent to be in the trial

You may not qualify if:

  • Age less than 16 years
  • Previous ipsilateral DCR or nasal surgery
  • Canalicular disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Eye Care Centre (Clinic)

Vancouver, British Columbia, Canada

Location

VGH/UBC (Operating Rooms)

Vancouver, British Columbia, Canada

Location

MeSH Terms

Conditions

Lacrimal Duct Obstruction

Condition Hierarchy (Ancestors)

Lacrimal Apparatus DiseasesEye Diseases

Study Officials

  • Peter Dolman, MD

    University of British Columbia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 4, 2008

First Posted

November 5, 2008

Study Start

November 1, 2008

Primary Completion

June 2, 2016

Study Completion

June 2, 2016

Last Updated

March 3, 2017

Record last verified: 2017-03

Locations